Impaired platelet aggregation and abnormal activation of GPIIb-IIIa
Gabbeta, J.; Rao, A.K.
Thrombosis and Haemostasis 78(4): 1302
1997
ISSN/ISBN: 0340-6245 PMID: 9365007 Document Number: 480375
Document emailed within 1 workday
Related Documents
Jennings, L.K.; White, M.M.; Mandrell, T.D. 1995: Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity Thrombosis and Haemostasis 74(6): 1551-1556Higashihara, M.; Maeda, H.; Ohashi, T.; Oka, H.; Kume, S. 1987: The effect of a monoclonal antibody specific for human platelet GPIIb/IIIa (TP80) on platelet function Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(4): 926-935
Collen, D.; Lu, H.R.; Stassen, J.M.; Vreys, I.; Yasuda, T.; Bunting, S.; Gold, H.K. 1994: Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis Thrombosis and Haemostasis 71(1): 95-102
Konstantopoulos, K.; Mousa, S.A. 2001: Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond Current Opinion in Investigational Drugs 2(8): 1086-1092
Liani, M.; Salvati, F.; Tresca, E.; Di Paolo, G.; Vitacolonna, L.; Golato, M.; Velussi, C. 1996: Arteriovenous fistula obstruction and expression of platelet receptors for von Willebrand factor and for fibrinogen (glycoproteins GPib and GPiib/iiia) in hemodialysis patients International Journal of Artificial Organs 19(8): 451-454
Müller, T.H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J. 1997: Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men Circulation 96(4): 1130-1138
Cattaneo, M.; Pareti, F.I.; Zighetti, M.; Lecchi, A.; Lombardi, R.; Mannucci, P.M. 1995: Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time Journal of Laboratory and Clinical Medicine 125(4): 540-547
Byzova, T.V.; Vlasik, T.N.; Mazurov, A.V. 1994: Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex Biulleten' Eksperimental'noi Biologii i Meditsiny 118(10): 402-405
Biran, H.; Stern, J.; Dvilansky, A. 1972: Impaired platelet aggregation after Echis colorata bite in man Israel Journal of Medical Sciences 8(10): 1757
Hutspardol, S.; Chuansamrit, A.; Soisamrong, A. 2010: Spontaneous subgaleal hemorrhage in a girl with impaired adrenaline-induced platelet aggregation Journal of the Medical Association of Thailand 93(5): 625-628
Cook, N.S.; Bruttger, O.; Pally, C.; Hagenbach, A. 1993: The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active Thrombosis and Haemostasis 70(5): 838-847
Malmgren, R.; Thorsen, T.; Nordvik, A.; Holmsen, H. 1993: Microbubble-induced phospholipase C activation does not correlate with platelet aggregation Thrombosis and Haemostasis 69(4): 394-396
Akarasereenont, P.; Chotewuttakorn, S.; Aiamsa-Ard, T.; Thaworn, A. 2001: The activation of platelet aggregation by human cholangiocarcinoma cells is mediated through thrombin receptor Journal of the Medical Association of Thailand 84(Suppl 3): S710-S721
Xu, H.; Frojmovic, M.M.; Wong, T.; Rauch, J. 1995: Inhibition of platelet aggregation by an SLE-derived human hybridoma autoantibody against an activation-dependent antigen Thrombosis and Haemostasis 74(4): 1152-1162
Campbell, A.L.; Pierangeli, S.S.; Wellhausen, S.; Harris, E.N. 1995: Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation Thrombosis and Haemostasis 73(3): 529-534
Ambrus, J.L.; Ambrus, C.M.; Gastpar, H.; Williams, P. 1982: Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis Journal of Medicine 13(1-2): 35-47
Iioka, H.; Hisanaga, H.; Moriyama, I.; Akasaki, M.; Nabuchi, K.; Katakami, Y.; Katoh, Y.; Ichijo, M. 1989: The study on the platelet aggregation inhibition activity of placental brush border (the mechanism of platelet aggregation inhibition) Nihon Sanka Fujinka Gakkai Zasshi 41(12): 1916-1920
Heinrich, D.; Scharf, T.; Santoso, S.; Clemetson, K.J.; Mueller-Eckhardt, C. 1985: Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa. II. Different effects on platelet function Thrombosis Research 38(5): 547-559
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993
Armstrong, R.; May, J.A.; Lösche, W.; Heptinstall, S. 1995: Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood Thrombosis and Haemostasis 73(2): 297-303